Atlas Trials

Kowa Research Institute, Inc.

47 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kowa Research Institute, Inc.

RecordFirmDate
Trial to Investigate the Safety and Effectiveness of the KI-362-US1 (YP2.2VM) Intraocular Lens (IOL) in Adult Participants for Correction of Aphakia Following Cataract Extraction (NCT07650201)Kowa Research Institute, Inc.2026-08-01
A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. (NCT06525311)Kowa Research Institute, Inc.2024-10-01
Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. (NCT06247735)Kowa Research Institute, Inc.2024-02-07
A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) (NCT05826353)Kowa Research Institute, Inc.2023-05-11
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD) (NCT05795699)Kowa Research Institute, Inc.2023-03-30
Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452 (NCT05722262)Kowa Research Institute, Inc.2023-02-24
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis (NCT05327127)Kowa Research Institute, Inc.2022-11-14
A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery (NCT05528172)Kowa Research Institute, Inc.2022-08-04
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease (NCT05403827)Kowa Research Institute, Inc.2022-07-03
Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers (NCT04742218)Kowa Research Institute, Inc.2021-01-13
A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle Soreness (DOMS) in the Lower Extremity (NCT04484428)Kowa Research Institute, Inc.2020-08-15
Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis (NCT04250207)Kowa Research Institute, Inc.2020-06-23
Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR (NCT04447820)Kowa Research Institute, Inc.2020-06-10
Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers (NCT04237597)Kowa Research Institute, Inc.2019-12-17
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease (NCT04084483)Kowa Research Institute, Inc.2019-08-04
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults. (NCT03702673)Kowa Research Institute, Inc.2018-10-05
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults (NCT03712241)Kowa Research Institute, Inc.2018-10-04
Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100 (NCT03505567)Kowa Research Institute, Inc.2018-04-21

Track Kowa Research Institute, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.